MitoSure® provides an estimate of the amount of mitochondrial DNA present in an embryo relative to nuclear DNA. An abnormally high MitoSure® score (above 2) may be indicative of developmental delay. When selecting viable embryos for implantation, MitoSure® may be of use as a novel biomarker for the deselection of unfit embryos.


Your results are available through our online portal, Revela®. The test is performed simultaneously with Previda®. The role of mitochondrial content in IVF is an ongoing research field. Your physician will review the results and may consider your MitoSure® Score as additional information to help identify promising embryos for transfer.


At Progenesis, our patients are our highest priority.

We are happy to address any of your questions or concerns.